drugset / Trial / NCT02449330

Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study

NCT02449330

RandomizedParallel-groupSingle-blindTreatment

Summary

This is the clinical trial designed to assess the cardiac diastolic function of long term treatment with teneligliptin compared to that without teneligliptin in patients with type 2 diabetes mellitus by two arms; one includes patients showing E/e' by echocardiography less than 8, the other includes patients showing E/e' by echocardiography more than 8.

Timeline

Start
2015-06
Primary completion
2020-06
Completion
2023-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Teneligliptin Small molecule